Less Ads, More Data, More Tools Register for FREE

Pin to quick picksPHC.L Regulatory News (PHC)

  • There is currently no data for PHC

Potato yield increased through PHC's Harpin

27 Jul 2012 07:00

RNS Number : 6418I
Plant Health Care PLC
27 July 2012
 



27 July, 2012

 

 

 

Plant Health Care plc

("Plant Health Care," "PHC" or "the Company")

 

POTATO YIELD INCREASED AND STORAGE LOSSES REDUCED

THROUGH PHC'S PROPRIETARY HARPIN TREATMENT

 

Plant Health Care (AIM: PHC), a leading provider of naturally derived products to the agriculture industry, announces that in recent trials it was found that potatoes, when treated with PHC's proprietary Harpin technology while still in the field, produced a 4.4% greater marketable yield at harvest and a reduced loss in long-term (7-8 month) storage from 4.6% in the untreated to 1.9% in the treated tubers. The storage improvements alone are worth about $4 per ton, which equates to $20,000 for a 5,000 ton storage building. These results were achieved in trials conducted by independent crop consultants using commercial production practices in grower fields in Washington and Idaho.

 

Harpin technology is available for all major crops. The Harpins bind to receptors on the surface of the plant leaf, causing a reaction where the plant gears up to defend itself against disease. This is the well-documented Systematic Acquired Resistance (SAR) response, which affects the yield quality and shelf life of the crops. PHC currently has several testing agreements with major companies looking at disease control, yield increase and longer, post- harvest, shelf life achieved through the combined use of Harpin and fungicide.

 

Paul Bystrak, PHC Field Scientist, commented: "We had already seen evidence in smaller-scale studies that the long-term storability of potatoes increased following in-field Harpin treatment, so it is very encouraging to have those results verified on a larger scale. We have also demonstrated similar results in a variety of crops ranging from lettuce to citrus, so the financial savings potential for the grower should prove to be very attractive."

 

Steve Holland, a crop consultant who conducted several of the trials, commented:"The growers we worked with in the Columbia Basin have become extremely proficient at storing potatoes, so it was heartening to see the additional benefits realized by the use of Harpin in storage. In addition, substantial benefits were also realized in each of the other trials that were focused solely on studying the yield benefits."

 

~ ENDS ~

 

 

 

For further information please contact:

 

Plant Health Care plc

John Brady, Chief Executive Officer

Tel: +1-603-525-3702

jabrady@planthealthcare.com

Stephen Weaver, Finance Director

Tel: +1-412-826-5488 x151

sweaver@planthealthcare.com

Nomura Code Securities

Tel: +44 (0) 20 7776 1200

Clare Terlouw / Chris Golden

www.nomuracode.com

Powerscourt

Tel: +44 (0) 20 7250 1446

Paul Durman / Nick Dibden

 

 

About Plant Health Care plc:

 

Plant Health Care plc ("PHC") is a leading provider of naturally-derived products for plants and soil. Established in 1995 in Pittsburgh (Pennsylvania) in the United States, PHC currently has approximately 40 employees and has operations in the United States, Mexico, the United Kingdom, Spain and the Netherlands. The Company's ordinary shares have been quoted on the Alternative Investment Market ("AIM") of the London Stock Exchange since July 2004 and listed on the Official List of the Channel Islands Stock Exchange ("CISX") since February 2010 (ticker symbol/ mnemonic: PHC).

 

PHC's products are aimed at agriculture industries and are environmentally beneficial. Through the commercialisation of these products, PHC is capitalising on current long-term trends toward natural systems and biological products for plant care and soil and water management. Further information is available at: www.planthealthcare.com.

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
NRARFMRTMBBTBIT
Date   Source Headline
28th Jun 202312:29 pmRNSHolding(s) in Company
27th Jun 20234:08 pmRNSHolding(s) in Company
27th Jun 20231:08 pmRNSDirector Shareholding
23rd Jun 20237:00 amRNSResult of Fundraising
22nd Jun 20234:35 pmRNSFundraising to raise up to US$3.6 million
14th Jun 20237:00 amRNSWilbur Ellis Agreement
13th Jun 20231:43 pmRNSResult of AGM
30th May 20237:00 amRNSHolding(s) in Company
24th May 20231:12 pmRNSHolding(s) in Company
19th May 20235:55 pmRNSPublication of Annual Report and Notice of AGM
18th May 20237:00 amRNSResult of Consultation
9th May 20237:00 amRNSPHC68949 granted first stage of approval in Brazil
2nd May 20237:10 amRNSResults for the year ended 31 December 2022
12th Apr 20232:33 pmRNSNotice of Results
5th Apr 20235:29 pmRNSHolding(s) in Company
8th Mar 20232:45 pmRNSExercise of Options
2nd Mar 20237:00 amRNSBiofungicide PHC279 Approved by US EPA
1st Mar 20237:00 amRNSDirector/PDMR Shareholding
6th Feb 20237:00 amRNSTrading Statement
30th Jan 202312:08 pmRNSSignificant Shareholder
18th Jan 20237:00 amRNSBoard Appointments
12th Jan 20237:00 amRNSNovozymes Distribution Agreement
9th Jan 20237:00 amRNSInvestor Presentation
22nd Dec 20227:00 amRNSNew Products Submitted for Regulatory Approval
28th Oct 20227:00 amRNSRegistration of Harpin in France
28th Oct 20227:00 amRNSNew distribution agreement with EDAF
27th Oct 20227:00 amRNSTrading Update
14th Oct 20225:11 pmRNSDirector/PDMR Shareholding
14th Oct 202210:39 amRNSDirector / PDMR Shareholding
26th Sep 20227:00 amRNSInterim Results
22nd Aug 20227:00 amRNSTrials agreement signed with Agrii UK
12th Aug 20227:00 amRNSGrant of Options
10th Aug 20225:04 pmRNSDirector/PDMR Shareholding
21st Jul 20222:41 pmRNSHolding(s) in Company
18th Jul 20227:02 amRNSInvestor Presentation
18th Jul 20227:00 amRNSPost-Close Trading Update
22nd Jun 202212:37 pmRNSResult of AGM
21st Jun 20227:00 amRNSCompletion of Nominated Adviser due diligence
20th Jun 20227:00 amRNSLong-term Harpin Production and Supply Agreement
6th Jun 20228:00 amRNSHolding(s) in Company
6th Jun 20228:00 amRNSHolding(s) in Company
1st Jun 20222:31 pmRNSDirector/PDMR Shareholding
25th May 20225:23 pmRNSHolding(s) in Company
23rd May 20227:30 amRNSAnnual Report & Accounts and Notice of AGM
23rd May 20227:00 amRNSNew distribution agreement with Nutrien
16th May 20227:00 amRNSHolding(s) in Company
12th May 20227:15 amRNSCEO appointment and Board changes
12th May 20227:00 amRNSResults for the year ended 31 December 2021
28th Apr 20227:00 amRNSChange of Adviser
21st Apr 20222:27 pmRNSDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.